Cover of New Drugs

New Drugs

United States

3 ideas

Buy on Amazon

An insider's guide to how a new medicine moves from target to FDA approval, covering trial phases, why most candidates fail, and why statistical proof of benefit is central.

  1. The stages from target to approval

    Friedhoff lays out the pipeline: identifying a biological target, screening compounds, preclinical testing, then Phase I safety, Phase II dosing, and Phase III efficacy trials before FDA review. Each gate exists to answer a specific question and most candidates die at one of them.

  2. Why most drugs fail

    The book explains that the vast majority of candidates fail for lack of efficacy or unacceptable toxicity discovered only in humans. This attrition, not greed alone, drives the enormous cost and time of bringing a drug to market.

  3. Statistical proof is the real product

    Friedhoff, who led development of a major Alzheimer's drug, stresses that approval hinges on rigorous, prespecified trials that statistically prove benefit over placebo. The science of proving a drug works is as demanding as the chemistry of making it.

Save ideas and give them a thumbs up or down in the app